• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

The “dark side” of contemporary medical imaging or, Too much of a good thing!

  • Mon, 11/8/10 - 11:35am
  • 1296 reads
  • 1 comments



I’d bet a dime most readers would agree that advances with diagnostic imaging are the foundation for many if not most good things happening in contemporary medicine. And nowhere is this truer than in the “aortic space” where specialists (such as myself) have come to depend heavily on CT scans (with and without 3D reconstructions) for diagnosis, measurements and sizing, procedure planning, and patient follow-up in the context of endovascular repair of aneurysms and other aortic pathologies.

Unfortunately, these patients require relatively intense surveillance and follow-up, meaning that they may be exposed to an enormous cumulative amount of radiation across many years to come. Driven by such concerns, I penned a VDM editorial in 2009 (Ref. 1). The following excerpts represent the substance of the message therein contained:

“We now use this imaging capability (CT scanning) for diagnosis, pre-operative assessment and procedure planning, stent-graft device sizing, as well as patient follow-up and surveillance — lifelong. Furthermore, it is clear that the impact of modern medical imaging is being felt much beyond aortic intervention, inducing transformational influence in — essentially — every anatomy-centered area of medicine. Today, a great number of patients enjoy the advantages of precise diagnosis and treatment with less invasive technologies in a manner that is increasingly safe and successful. Importantly, though, and on the downside, these patients are also being exposed to significant doses of radiation over time. Fazel et al focused on this very issue in a recent study (Ref. 2). They found that, indeed, ‘imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation’. Computed tomography (CT) scans and nuclear imaging accounted for 75.4%
of the cumulative effective dose, and more than 80% of the procedures were done in an outpatient setting. In addition to radiation, economic costs are another source of concern related to the widespread and ever-increasing use of medical imaging in this country.

It was almost too good to be true, wasn’t it? Just when we were finally feeling at the very top of our game… we are now beginning to hear this should perhaps be slowed down and that we ought to re-think some of the diagnostic and surveillance strategies. I, for one, would not be surprised to see attempts (from various corners) to restrict and/or micro-manage physicians’ ability to order and perform imaging procedures in the near future. From that perspective, it would be in our best interest to become proactive in proposing and implementing reasonable guidelines that experts and professional societies can hopefully agree on — as opposed to impositions coming from outside entities. It may well be our best chance to retain the ability to use advanced imaging modalities in a manner that contributes to the ultimate goal of best patient care but, at the same time, minimizes costs in terms of economic expense and excessive exposure to radiation.”

References
1. Criado FJ. Medical imaging in the XXI Century: Too much of a good thing? Vasc Dis Management 2009;6:A4.
2. Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009;361:849-857.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Tallinsays: April 23.2011 at 10:23 am

THX that's a great awnesr!

Reply to this comment »

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications